Drug Topics Community Pharmacists' Report

October 9, 2012

Web Version  |   Unsubscribe  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TOP STORY

Court says pharmacists can refuse to sell Plan B

An Illinois appeals court recently upheld a ruling that pharmacists are permitted to refrain from prescribing emergency contraceptives, finding that healthcare professionals are protected by an Illinois state law. » More

Continuing Education

New CPE Series: MTM in Patients with Diabetes

Welcome to a new CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 CPE credits from September 2012-March 2013 with 7 monthly knowledge-based activities. This month, the professional development activity will cover the pathophysiology, diagnosis, screening, and risk factors associated with diabetes mellitus.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

TODAY'S HEADLINES

Meningitis outbreak kills 8, sickens more than 100

The Centers for Disease Control and Prevention reported as of Oct. 9 that 105 patients have developed fungal meningitis and eight have died after receiving epidural steroid injections with contaminated methylprednisolone acetate, which was recalled from New England Compounding Center on Sept. 26. » More

Metformin effective, safe in type 2 diabetes patients, regardless of renal function

Metformin is a safe and effective drug for the treatment of type 2 diabetes and can be used in patients with varying degrees of renal impairment, according to a long-term observational study that was published online in the British Medical Journal. » More

How long should beta-blockers be used in CAD patients?

While beta-blocker use continues to be the standard of care for patients with coronary artery disease, especially for those patients who have had a myocardial infarction, these drugs may not be effective long term, according to an online report published Oct. 3 in JAMA. » More

TAKE OUR SURVEY

Because of the recent meningitis outbreak linked to a compounding pharmacy, should FDA have greater oversight for compounding facilities to ensure drug safety and quality?

1. Yes
2. No

Respond here and see what your colleagues think, too.

Want to see the results of our last survey about who your colleagues are voting for in the upcoming election? Click here.

 

Subscribe Now!

You must click here to continue receiving the Drug Topics Community Pharmacists' Report

Check these out, too

FDA: green light given for diabetes tablet

Generic antidepressant taken off market

$700 million fine from off-label promotion

Survey examines young adult Rx drug abuse

Voices

DT Blog: OSHA says, "Oh yes, you can"

JP at Large: Over the line

View from the Zoo: A pharmacy parable

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News, features, analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group